Global burden of hypertension: analysis of worldwide data, The Lancet, vol.365, issue.9455, pp.217-223, 2005. ,
DOI : 10.1016/S0140-6736(05)70151-3
Niveau tensionnel moyen et prévalence de l'hypertension artérielle chez les adultes de 18 à 74 ans, Étude Nationale Nutrition Santé, 2006. ,
Resistant Hypertension: Diagnosis, Evaluation, and Treatment: A Scientific Statement From the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research, Hypertension, vol.51, issue.6, pp.1403-1422, 2008. ,
DOI : 10.1161/HYPERTENSIONAHA.108.189141
Uncontrolled and Apparent Treatment Resistant Hypertension in the United States Circulation, NHANES survey, 1988. ,
Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community, Hypertension, vol.36, pp.594-599, 2000. ,
Treatment and control of hypertension in the community: a prospective analysis, Hypertension, vol.40, pp.640-646, 2002. ,
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study, Circulation, vol.117, issue.6, p.743, 2008. ,
DOI : 10.1161/CIRCULATIONAHA.107.699579
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid- Lowering Treatment to Prevent Heart Attack Trial (ALLHAT), JAMA, vol.288, pp.2981-2997, 2002. ,
Effect of longer-term modest salt reduction on blood pressure ,
Dietary Sodium Restriction as Adjunctive Treatment of Hypertension, JAMA: The Journal of the American Medical Association, vol.259, issue.17, pp.2561-2565, 1988. ,
DOI : 10.1001/jama.1988.03720170037030
Evaluating the True Prevalence of Resistant Hypertension, Hypertension, vol.58, issue.4, 2011. ,
DOI : 10.1161/HYPERTENSIONAHA.111.178111
Effects ofdietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial, Hypertension, vol.54, issue.3, pp.475-481, 2009. ,
Effects of Diet and Sodium Intake on Blood Pressure: Subgroup Analysis of the DASH-Sodium Trial, Annals of Internal Medicine, vol.135, issue.12, pp.1019-1028, 2001. ,
DOI : 10.7326/0003-4819-135-12-200112180-00005
Alcohol intake and hypertension subtypes in Chinese men, Journal of Hypertension, vol.23, issue.4, pp.737-743, 2005. ,
DOI : 10.1097/01.hjh.0000163141.82212.5f
Effect of Alcohol Abstinence on Blood Pressure : Assessment by 24-Hour Ambulatory Blood Pressure Monitoring, Hypertension, vol.33, issue.2, pp.653-657, 1999. ,
DOI : 10.1161/01.HYP.33.2.653
Effect of Aerobic Exercise on Blood Pressure, Annals of Internal Medicine, vol.136, issue.7, pp.493-503, 2002. ,
DOI : 10.7326/0003-4819-136-7-200204020-00006
Treatment of Patients with Hypertension and Arthritis Pain: New Concepts, The American Journal of Medicine, vol.122, issue.5, pp.16-22, 2009. ,
DOI : 10.1016/j.amjmed.2009.03.004
Frequency of Analgesic Use and Risk of Hypertension in Younger Women, Archives of Internal Medicine, vol.162, issue.19, pp.2204-2208, 2002. ,
DOI : 10.1001/archinte.162.19.2204
Nonnarcotic analgesic use and the risk of hypertension in US women, Hypertension, vol.40, issue.5, pp.604-608, 2002. ,
Do Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-Analysis, Annals of Internal Medicine, vol.121, issue.4, pp.289-300, 1994. ,
DOI : 10.7326/0003-4819-121-4-199408150-00011
Do Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-Analysis, Annals of Internal Medicine, vol.121, issue.4, pp.289-300, 1994. ,
DOI : 10.7326/0003-4819-121-4-199408150-00011
Ibuprofen Interferes with the Efficacy of Antihypertensive Drugs, Annals of Internal Medicine, vol.107, issue.5, pp.628-635, 1987. ,
DOI : 10.7326/0003-4819-107-5-628
Effect of Indomethacin on Blood Pressure Lowering by Captopril and Losartan in Hypertensive Patients, Hypertension, vol.36, issue.3, pp.461-465, 2000. ,
DOI : 10.1161/01.HYP.36.3.461
Prostaglandins in blood pressure regulation, Kidney International, vol.34, issue.25, pp.57-60, 1988. ,
COX-2 and beyond: approaches to prostaglandin inhibition in human disease, Nature Reviews Drug Discovery, vol.5, issue.11, pp.879-890, 2003. ,
DOI : 10.1038/384644a0
Effects of Celecoxib and Naproxen on Renal Function in the Elderly, Archives of Internal Medicine, vol.160, issue.10, pp.1465-1470, 2000. ,
DOI : 10.1001/archinte.160.10.1465
Comparison of the COX-inhibiting nitric oxide donator AZD3582 and rofecoxib in treating the signs and symptoms of Osteoarthritis of the knee, Arthritis & Rheumatism, vol.90, issue.6, pp.827-837, 2005. ,
DOI : 10.1002/art.21586
Efficacy, safety, and effects on blood pressure of naproxcinod 750 mg twice daily compared with placebo and naproxen 500 mg twice daily in patients with osteoarthritis of the hip: A randomized, double-blind, parallel-group, multicenter study, Arthritis & Rheumatism, vol.25, issue.12, pp.3635-3644, 2010. ,
DOI : 10.1002/art.27694
Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison, Improving Access to Quality Care in Family Planning: Medical Eligibility Criteria for Contraceptive Use, pp.1771-1781, 1996. ,
DOI : 10.1016/S0140-6736(06)69666-9
Angiogenesis Inhibitors and Hypertension: An Emerging Issue, Journal of Clinical Oncology, vol.24, issue.9, pp.1329-1331, 2006. ,
DOI : 10.1200/JCO.2005.04.5740
Possible molecular mechanisms involved in the toxicity of angiogenesis inhibition, Nature Reviews Cancer, vol.290, issue.6, pp.475-485, 2009. ,
DOI : 10.1038/nrc2152
Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories, BMJ, vol.336, issue.7653, pp.1114-1117, 2008. ,
DOI : 10.1136/bmj.39553.670231.25
Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy, Journal of Hypertension, vol.26, issue.4, pp.819-824, 2008. ,
DOI : 10.1097/HJH.0b013e3282f4edd7
Intensive Monitoring of Adherence to Treatment Helps to Identify ???True??? Resistant Hypertension, The Journal of Clinical Hypertension, vol.288, issue.1 suppl 1, pp.183-191, 2009. ,
DOI : 10.1111/j.1751-7176.2009.00102.x
Clinical Characteristics of Resistant Hypertension: The Importance of Compliance and the Role of Diagnostic Evaluation in Delineating Pathogenesis, The Journal of Clinical Hypertension, vol.48, issue.2, pp.7-12, 2007. ,
DOI : 10.1111/j.1524-6175.2007.6106.x
Resistant Hypertension: Identifying Causes and Optimizing Treatment Regimens, Southern Medical Journal, vol.101, issue.2, pp.166-173, 2008. ,
DOI : 10.1097/SMJ.0b013e31816171cb
Clinical Inertia, Annals of Internal Medicine, vol.135, issue.9, pp.825-834, 2001. ,
DOI : 10.7326/0003-4819-135-9-200111060-00012
National Utilization of Antihypertensive Medications From 2000 to 2006 in the Veterans Health Administration: Focus on Thiazide Diuretics, The Journal of Clinical Hypertension, vol.145, issue.10, pp.770-778, 2008. ,
DOI : 10.1111/j.1751-7176.2008.00019.x
US Trends in Prevalence, Awareness, Treatment, and Control of Hypertension, 1988-2008, JAMA, vol.303, issue.20, pp.2043-2050, 1988. ,
DOI : 10.1001/jama.2010.650
2007 Guidelines for the Management of Arterial Hypertension, Journal of Hypertension, vol.25, issue.6, pp.1105-1187, 2005. ,
DOI : 10.1097/HJH.0b013e3281fc975a
Resistant Hypertension Revisited: A Comparison of Two University-Based Cohorts, American Journal of Hypertension, vol.18, issue.5, pp.619-626, 2005. ,
DOI : 10.1016/j.amjhyper.2004.11.021
Efficacy of morning and evening dosing of amlodipine/valsartan combination hypertensive patients uncontrolled by 5 mg of amlodipine Blood Press Monit, pp.80-86, 2011. ,
Results of combination antihypertensive therapy after failure of each of the components. Department of Veterans Affairs Cooperative Study Group on Anti-hypertensive Agents, J Hum Hypertens, vol.9, pp.791-796, 1995. ,
Resistant Hypertension: Comparing Hemodynamic Management to Specialist Care, Hypertension, vol.39, issue.5, pp.982-988, 2002. ,
DOI : 10.1161/01.HYP.0000016176.16042.2F
Comparative Antihypertensive Effects of Hydrochlorothiazide and Chlorthalidone on Ambulatory and Office Blood Pressure, Hypertension, vol.47, issue.3, pp.352-358, 2006. ,
DOI : 10.1161/01.HYP.0000203309.07140.d3
Chronotherapy Improves Blood Pressure Control and Reverts the Nondipper Pattern in Patients With Resistant Hypertension, Hypertension, vol.51, issue.1, pp.69-76, 2008. ,
DOI : 10.1161/HYPERTENSIONAHA.107.096933
Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic Hypertension, Systolic Hypertension in Europe Trial Investigators, pp.539-546, 1999. ,
DOI : 10.1001/jama.282.6.539
Ambulatory Blood Pressure and 10-Year Risk of Cardiovascular and Noncardiovascular Mortality: The Ohasama Study, Hypertension, vol.45, issue.2, pp.240-245, 2005. ,
DOI : 10.1161/01.HYP.0000152079.04553.2c
The role of spironolactone in the treatment of patients with refractory hypertension, American Journal of Hypertension, vol.15, issue.4, pp.333-339, 2002. ,
DOI : 10.1016/S0895-7061(01)02342-1
Efficacy of low-dose spironolactone in subjects with resistant hypertension, American Journal of Hypertension, vol.16, issue.11, pp.925-930, 2003. ,
DOI : 10.1016/S0895-7061(03)01032-X
Efficacy of spironolactone therapy in patients with true resistant hypertension The Spironolactone, Amiloride, Losartan, and Thiazide (SALT) double-blind crossover trial in patients with low renin hypertension and elevated aldosterone 72 Anti-vascular endothelial growth factor (VEGF) therapy: a new cause of secondary hypertension. Rev Prat, Urgences néphrologiques et transplantation rénale, Inserm U702, hôpital Tenon, pp.147-152644, 2010. ,
Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis, The Lancet Oncology, vol.9, issue.2, pp.117-123, 2008. ,
DOI : 10.1016/S1470-2045(08)70003-2
Obstructive Sleep Apnea: Diagnosis, Epidemiology, and Economics. Respiratory Care, septembre 2010, p.9 ,
Association of Sleep-Disordered Breathing, Sleep Apnea, and Hypertension in a Large Community-Based Study, JAMA, vol.283, issue.14, pp.1829-1836, 2000. ,
DOI : 10.1001/jama.283.14.1829
Prospective Study of the Association between Sleep-Disordered Breathing and Hypertension, New England Journal of Medicine, vol.342, issue.19, pp.1378-1384, 2000. ,
DOI : 10.1056/NEJM200005113421901
High prevalence of unrecognized sleep apnoea in drug-resistant hypertension, Journal of Hypertension, vol.19, issue.12, pp.2271-2277, 2001. ,
DOI : 10.1097/00004872-200112000-00022
Sleep-related breathing disorder is an independent risk factor for uncontrolled hypertension, Journal of Hypertension, vol.18, issue.6, pp.679-685, 2000. ,
DOI : 10.1097/00004872-200018060-00004
Sleep Apnea Syndrome: A Possible Contributing Factor to Resistant Hypertension, Sleep, vol.24, issue.6, pp.721-725, 2001. ,
DOI : 10.1093/sleep/24.6.721
Sympathetic neural mechanisms in obstructive sleep apnea., Journal of Clinical Investigation, vol.96, issue.4, pp.1897-1904, 1995. ,
DOI : 10.1172/JCI118235
Obstructive Sleep Apnea-Dependent and -Independent Adrenergic Activation in Obesity, Hypertension, vol.46, issue.2, pp.321-325, 2005. ,
DOI : 10.1161/01.HYP.0000174243.39897.6c
Plasma Levels of Nitric Oxide and L-Arginine in Sleep Apnea Patients: Effects of nCPAP Treatment, Journal of Molecular Neuroscience, vol.21, issue.1, pp.57-63, 2003. ,
DOI : 10.1385/JMN:21:1:57
Sleep {middle dot} 6: Obstructive sleep apnoea/hypopnoea syndrome and hypertension, Thorax, vol.59, issue.12, pp.1089-1094, 2004. ,
DOI : 10.1136/thx.2003.015875
Presidential address. Part I. Painting background. Part II. Primary aldosteronism, a new clinical syndrome Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism, Journal of Laboratory and Clinical Medicine Annals of Internal Medicine, vol.45, issue.66 6, pp.3-17, 1955. ,
Changes in the Perceived Epidemiology of Primary Hyperaldosteronism, International Journal of Hypertension, vol.341, issue.7258, p.162804, 2011. ,
DOI : 10.2215/CJN.04750908
Is There an Unrecognized Epidemic of Primary Aldosteronism? (Con), Hypertension, vol.50, issue.3, pp.454-458, 2007. ,
DOI : 10.1161/HYPERTENSIONAHA.106.086124
Primary aldosteronism, Rev Med Chil, 2008. ,
Primary Hyperaldosteronism in Essential Hypertensives: Prevalence, Biochemical Profile, and Molecular Biology, Journal of Clinical Endocrinology & Metabolism, vol.85, issue.5, pp.1863-1867, 2000. ,
DOI : 10.1210/jc.85.5.1863
Primary aldosteronism???careful investigation is essential and rewarding, Molecular and Cellular Endocrinology, vol.217, issue.1-2, pp.33-39, 2004. ,
DOI : 10.1016/j.mce.2003.10.006
Diagnosis of primary aldosteronism: from screening to subtype differentiation, Trends in Endocrinology & Metabolism, vol.16, issue.3, pp.114-119, 2005. ,
DOI : 10.1016/j.tem.2005.02.007
Hyperaldosteronism Among Black and White Subjects With Resistant Hypertension, Hypertension, vol.40, issue.6, pp.892-896, 2002. ,
DOI : 10.1161/01.HYP.0000040261.30455.B6
Screening for primary aldosteronism without discontinuing hypertensive medications: Plasma aldosterone-renin ratio, American Journal of Kidney Diseases, vol.37, issue.4, pp.699-705, 2001. ,
DOI : 10.1016/S0272-6386(01)80117-7
Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study, The Lancet, vol.371, issue.9628, pp.1921-1926, 2008. ,
DOI : 10.1016/S0140-6736(08)60834-X
Common Secondary Causes of Resistant Hypertension and Rational for Treatment, International Journal of Hypertension, vol.281, issue.6248, 236239. ,
DOI : 10.1016/S0140-6736(09)60566-3
Detecting and Treating Primary Aldosteronism, Experimental and Clinical Endocrinology & Diabetes, vol.115, issue.3, pp.171-175, 2007. ,
DOI : 10.1055/s-2007-970409
High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients J Hypertens, 2003. ,
Primary aldosteronism : Part I, J Nephrol, vol.21, pp.447-454, 2008. ,
Primary aldosteronism: part II: subtype differentiation and treatment, J Nephrol, vol.21, issue.4, pp.455-62, 2008. ,
Systematic Review: Diagnostic Procedures to Differentiate Unilateral From Bilateral Adrenal Abnormality in Primary Aldosteronism, Annals of Internal Medicine, vol.151, issue.5, pp.329-366, 2009. ,
DOI : 10.7326/0003-4819-151-5-200909010-00007
Weight Loss and the Renin-Angiotensin-Aldosterone System, Hypertension, vol.45, issue.3, pp.356-362, 2005. ,
DOI : 10.1161/01.HYP.0000154361.47683.d3
Human adipocytes secrete mineralocorticoid-releasing factors, Proceedings of the National Academy of Sciences, vol.100, issue.24, pp.14211-14216, 2003. ,
DOI : 10.1073/pnas.2336140100
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC283571
Severity of obstructive sleep apnea is related to aldosterone status in subjects with resistant hypertension, Journal of Clinical Sleep Medicine, vol.6, issue.4, pp.363-368, 2010. ,
Aldosterone Excretion Among Subjects With Resistant Hypertension and Symptoms of Sleep Apnea, Chest, vol.125, issue.1, pp.112-117, 2004. ,
DOI : 10.1378/chest.125.1.112
Renal-Artery Stenosis, New England Journal of Medicine, vol.344, issue.6, pp.431-442, 2001. ,
DOI : 10.1056/NEJM200102083440607
Prevalence of renovascular disease in the elderly: A population-based study, Journal of Vascular Surgery, vol.36, issue.3, pp.443-51, 2002. ,
DOI : 10.1067/mva.2002.127351
Prevalence of renal artery stenosis in high-risk veterans referred to cardiac catheterization., Journal of Hypertension, vol.21, issue.6, pp.1157-1162, 2003. ,
DOI : 10.1097/00004872-200306000-00016
Progression of renal artery stenosis in patients undergoing cardiac catheterization, American Heart Journal, vol.136, issue.5, pp.913-918, 1998. ,
DOI : 10.1016/S0002-8703(98)70138-3
Contemporary imaging techniques for the diagnosis of renal artery stenosis, European Radiology, vol.9, issue.Suppl 5, pp.2219-2229, 2005. ,
DOI : 10.1007/s00330-005-2826-6
The Effect of Balloon Angioplasty on Hypertension in Atherosclerotic Renal-Artery Stenosis, New England Journal of Medicine, vol.342, issue.14, pp.1007-1014, 2000. ,
DOI : 10.1056/NEJM200004063421403
Continuing uncertainty about the value of percutaneous revascularization in atherosclerotic renovascular disease: a meta-analysis of randomized trials, Nephrology Dialysis Transplantation, vol.18, issue.2, pp.298-304, 2003. ,
DOI : 10.1093/ndt/18.2.298
Diagnosis and treatment of renal artery stenosis, Nature Reviews Nephrology, vol.21, issue.3, pp.151-160, 2010. ,
DOI : 10.1038/nrneph.2009.230
Prevalence of High Blood Pressure and Elevated Serum Creatinine Level in the United States, Archives of Internal Medicine, vol.161, issue.9, pp.1207-1216, 1988. ,
DOI : 10.1001/archinte.161.9.1207
Controlling systolic blood pressure is difficult in patients with diabetic kidney disease exhibiting moderate???to???severe reductions in renal function, Blood Pressure, vol.12, issue.21, pp.170-176, 2005. ,
DOI : 10.1016/S0140-6736(96)11445-8
Sidhu SB Pheochromocytoma: current approaches and future directions Oncologist, pp.779-93, 2008. ,
Prognostic significance of 24-h ambulatory blood pressure characteristics for cardiovascular morbidity in a population of elderly men, Journal of Hypertension, vol.22, issue.9, pp.1691-1697, 2004. ,
DOI : 10.1097/00004872-200409000-00012
Prognostic Significance of Blood Pressure and Heart Rate Variabilities : The Ohasama Study, Hypertension, vol.36, issue.5, pp.901-906, 2000. ,
DOI : 10.1161/01.HYP.36.5.901
Secondary Hypertension in a Blood Pressure Clinic, Archives of Internal Medicine, vol.147, issue.7, pp.1289-1293, 1987. ,
DOI : 10.1001/archinte.1987.00370070103015
Year of Diagnosis, Features at Presentation, and Risk of Recurrence in Patients with Pheochromocytoma or Secreting Paraganglioma, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.4, pp.2110-2116, 2005. ,
DOI : 10.1210/jc.2004-1398
Prevalence of clinically unsuspected pheochromocytoma. Review of a 50-year autopsy series, Mayo Clinic Proc, vol.56, pp.354-360, 1981. ,
A Comparison of Biochemical Tests for Pheochromocytoma: Measurement of Fractionated Plasma Metanephrines Compared with the Combination of 24-Hour Urinary Metanephrines and Catecholamines, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.2, pp.553-558, 2003. ,
DOI : 10.1210/jc.2002-021251
Biochemical diagnosis of pheochromocytoma by simultaneous measurement of urinary excretion of epinephrine and norepinephrine, Clin Chem, vol.38, pp.486-492, 1992. ,
Potential pitfalls in the diagnosis of phaeochromocytoma, Med J Aust, vol.182, pp.637-640, 2005. ,
Biochemical Diagnosis of Pheochromocytoma, JAMA, vol.287, issue.11, pp.1427-1434, 2002. ,
DOI : 10.1001/jama.287.11.1427
Pheochromocytoma: New concepts and future trends, Kidney International, vol.40, issue.3, pp.544-556, 1991. ,
DOI : 10.1038/ki.1991.244
Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: Comparison with CT andMRI, J Nucl Med, vol.34, pp.173-179, 1993. ,
Pheochromocytoma: State-of-the-Art and Future Prospects, Endocrine Reviews, vol.24, issue.4, pp.539-553, 2003. ,
DOI : 10.1210/er.2002-0013
Diagnosis, localization and treatment of pheochromocytoma in MEN 2 syndrome Endocr Regul, pp.89-93, 2009. ,
SIDE-EFFECTS OF LONG-TERM TREATMENT WITH CORTICOSTEROIDS AND CORTICOTROPHIN, The Lancet, vol.283, issue.7343, pp.1121-1124, 1964. ,
DOI : 10.1016/S0140-6736(64)91804-5
Cortisol and the renal handling of electrolytes: role in glucocorticoid-induced hypertension and bone disease, Best Practice & Research Clinical Endocrinology & Metabolism, vol.17, issue.4, pp.575-589, 2003. ,
DOI : 10.1016/S1521-690X(03)00053-8
The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.5, pp.1526-1566, 2008. ,
DOI : 10.1210/jc.2008-0125
Circadian Blood Pressure Variations in Endocrine Disorders, Blood Pressure, vol.8, issue.1, pp.35-44, 1993. ,
DOI : 10.1161/01.HYP.12.1.11
Insulin Resistance and Cardiovascular Disease, Journal of Clinical Endocrinology & Metabolism, vol.86, issue.2, pp.713-718, 2001. ,
DOI : 10.1210/jc.86.2.713
Hypertension in patients with cushing???s disease: Pathophysiology, diagnosis, and management, Current Hypertension Reports, vol.42, issue.3, pp.212-218, 2005. ,
DOI : 10.1007/s11906-005-0013-4
Cardiovascular Risk In Cushing's Syndrome, Pituitary, vol.17, issue.4, pp.253-256, 2004. ,
DOI : 10.1007/s11102-005-1172-7
Left ventricular structural and functional characteristics in Cushing???s syndrome, Journal of the American College of Cardiology, vol.41, issue.12, pp.2275-2279, 2003. ,
DOI : 10.1016/S0735-1097(03)00493-5
Cardiovascular Risk Factors and Common Carotid Artery Caliber and Stiffness in Patients with Cushing???s Disease during Active Disease and 1 Year after Disease Remission, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.6, pp.2527-2533, 2003. ,
DOI : 10.1210/jc.2002-021558
Losartan in Cushing's syndrome, Methods and Findings in Experimental and Clinical Pharmacology, vol.20, issue.2, pp.163-168, 1998. ,
DOI : 10.1358/mf.1998.20.2.472459
Divergent Results Using Clinic and Ambulatory Blood Pressures: Report of a Darusentan-Resistant Hypertension Trial, Hypertension, vol.56, issue.5, pp.824-830, 2010. ,
DOI : 10.1161/HYPERTENSIONAHA.110.156976
Clinical Potential of Combined Organic Nitrate and Phosphodiesterase Type 5 Inhibitor in Treatment-Resistant Hypertension, Hypertension, vol.56, issue.1, pp.62-67, 2010. ,
DOI : 10.1161/HYPERTENSIONAHA.109.147686
Comparison of Nifedipine Alone and With Diltiazem or Verapamil in Hypertension, Hypertension, vol.28, issue.1, pp.109-114, 1996. ,
DOI : 10.1161/01.HYP.28.1.109
Carotid baroreceptor stimulation as a therapeutic target in hypertension and other cardiovascular conditions, Expert Opinion on Therapeutic Targets, vol.277, issue.4, pp.413-425, 2009. ,
DOI : 10.1161/01.RES.41.6.750
Rheos, Cardiology in Review, vol.19, issue.2, pp.52-59, 2011. ,
DOI : 10.1097/CRD.0b013e3181f87921
Implantable device therapy for the treatment of resistant hypertension J Cardiovasc Transl Res, pp.150-153, 2009. ,
Baroreflex Stimulation in Antihypertensive Treatment, Current Hypertension Reports, vol.6, issue.5 ,
DOI : 10.1007/s11906-010-0106-6
Chronic treatment of resistant hypertension with an implantable device: interim 2 year results of two studies of the Rheos hypertension system. The heart, 2009. ,
Novel Baroreflex Activation Therapy in Resistant Hypertension, Journal of the American College of Cardiology, vol.56, issue.15, pp.1254-1258, 2010. ,
DOI : 10.1016/j.jacc.2010.03.089
Renal Sympathetic Denervation and Systemic Hypertension, The American Journal of Cardiology, vol.105, issue.4, pp.570-576, 2010. ,
DOI : 10.1016/j.amjcard.2009.10.027
Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension, International Journal of Hypertension, vol.1, issue.5, 2011. ,
DOI : 10.1016/S0140-6736(10)62039-9
Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study, The Lancet, vol.373, issue.9671, pp.1275-1281, 2009. ,
DOI : 10.1016/S0140-6736(09)60566-3
Böhm M Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial Lancet, pp.1903-1912, 2010. ,
Epidemiology of Resistant Hypertension, The Journal of Clinical Hypertension, vol.371, issue.9628, 2011. ,
DOI : 10.1111/j.1751-7176.2011.00445.x
Volume d'Ejection Systolique (VES) x Fréquence Cardiaque (FC) ,
-le Système Nerveux Sympathique : via la sécrétion de catécholamines (retrouvées dans le Phéochromocytome) permet l'augmentation du DC et des RAS ,
Angiotensine-Aldostérone (SRAA) : effets vasoconstricteurs de l'angiotensine II et de la rétention hydro-sodée induite par l'aldostérone ,
la volémie et l'homéostasie du sel est assurée par la fonction régulatrice du rein : l'excrétion rénale est fonction du débit de filtration glomérulaire, de l'aldostérone ,